Navigation Links
Booster dose not required for Hepatitis B Vaccination

Alessandro Remo Zanetti and his colleagues from Institute of Virology, Italy has found that Initial vaccination with Hepatitis B produces the required concentrations of circulating antibodies in the blood of the patients for long periods//. The researchers have found that the circulating antibodies against Hepatitis B vaccination are present in the blood for at least 10 years after vaccination. Researchers have concluded that there is no need of booster doses of Hepatitis B in these patients as enough amount of antibodies are present which can give protection in case of Hepatitis B infection. The results of the work have been published in the journal The Lancet.

Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide. The World Health Organization (WHO) estimates that, globally, about 2 billion people have been infected with hepatitis B virus (HBV). More than 350 million people are chronically infected. WHO recommends that all countries should have universal infant or adolescent hepatitis B vaccination integrated into their national immunization programs.

The researchers conducted their trial in 1212 children’s and 446 Italian Air Force Recruits by vaccinating with Hepatitis B vaccination. They found that 64% of children and 89% of the recruits retained protective concentrations of antibodies. The study shows that infant and adolescent immune systems can recall responding to hepatitis B more than 10 years after immunization.

Experts View:

Professor Zanetti concludes: “In light of our findings, the use of routine booster doses of hepatitis B vaccine does not seem necessary to maintain long-term protection in immuno-competent individuals vaccinated as infants and teenagers."

Ding-Shinn Chen, National Taiwan University, Taiwan said, “Unless accumulating data show a significant increase of HBV infection in adolescents or adults who were vaccinated as children, a policy of booster vaccination in a population should not be recommended. We believe that this applies both to hyper-endemic and low endemic areas of the world.”

Source: News wise, The Lancet
'"/>




Related medicine news :

1. Need for Hepatitis Booster Questioned
2. Booster Dose Of Radiotherapy Beneficial In Early Breast Cancer
3. Booster Dose for Chickenpox Vaccine Recommended
4. Care for footwear not required diabetic patients
5. Advanced STD programs required
6. New Stem Cells lines will be required
7. Multi targeted approach required for suicide prevention in adolescents
8. More Funds required for Asian Countries to fight Bird Flu
9. Clergy blasts councilmans required-condom plan
10. Salmeterol - to be used in combination & only when required
11. Vitamin B for Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... WaterField ... for digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ... waxed canvas or ballistic nylon, the Duo is smartly designed for Dad’s ...
(Date:5/31/2016)... ... ... Interest is on the rise for using the CRISPR-Cas9 system for functional ... hit validation. A key reason may be that high-throughput synthesis—combined with a proprietary algorithm ... collections in arrayed formats. , Arrayed crRNA screens have the advantage ...
(Date:5/31/2016)... ... May 31, 2016 , ... MinerEye ... Vendors in Security Infrastructure Protection report by Gartner1 Inc. , Each year, Gartner ... research reports evaluating these innovative vendors and their products and services. , According ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... media enterprise focused on patients with cancer, has added Cancer and Careers ... website visitors with more timely content on continuing successful careers while fighting cancer. ...
(Date:5/30/2016)... Salt Lake City, Utah (PRWEB) , ... May ... ... health insurance reimbursement for small businesses, announced today the publication of an original ... helps business owners and health insurance professionals understand how Zane Benefits complies with ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... 2016 Hutchison China MediTech ... on the highly lucrative global oncology and immunology ... potential first-in-class or best-in-class tyrosine kinase inhibitor (TKI) ... strategic partners. HCM,s profitable Chinese healthcare business continues ... expect progress of the mid-to-late-stage pipeline during 2016-17 ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
Breaking Medicine Technology: